Anteris Technologies Global Corp.

NASDAQ:AVR

Medical - Devices

Healthcare
$5.21 -0.16%

-$0.02 today

Market cap
$507.94M
Beta
0.73
P/E (TTM)
-2.3
EPS (TTM)
-$4.04
52W Low $2.85High $10.14

Volume 1.24M

Average 1.18M

AVR EBITDA Margin

EBITDA as a percentage of revenue.

Anteris Technologies Global Corp.NASDAQ: AVR

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to -4443.3%

EBITDA Margin was -4443.3% in Q1 FY2026, down 576.1 pp from a year earlier. On a trailing-twelve-month basis it was -5021.0%, down 1760.3 pp year over year. Over 3 fiscal years it narrowed by 3924.4 pp.

Context

  • EBITDA Margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 3 analysts of -1075.8% for the fiscal year ending Dec 2026, up from -4834.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-4443.3%+4779.3 pp QoQ
Last fiscal yearDec 2025
-4834.9%-2083.2 pp YoY
LTMMar 2026
-5021.0%-1760.3 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-576.1 pp+2021.3 pp+2597.3 pp
1 year-2083.2 pp+3759.1 pp+5842.2 pp
3 years-3924.4 pp+4538.5 pp+8462.9 pp
5 years+4841.4 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-4834.9%
Year-over-year change
-2083.2pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How AVR compares with its peers on the latest reported figures

  • AVR's LTM Mar 2026 EBITDA Margin of -5021.0% is the lowest of the 6 companies compared; the peer median is 24.3%.
  • Its year-over-year change of -1760.3 pp is the lowest of 6, against a peer median of +2.2 pp.
  • Over three fiscal years its change of -3924.4 pp compares with a peer median of -0.9 pp.
AVR Competitors Peer median
EBITDA Margin for AVR and competitors
Company Period LTM level YoY 3-year change
BSXBoston Scientific CorporationLTM Jun 202627.6% +2.2 pp+3.8 pp
MDTMedtronic plcLTM Jul 202627.3% +0.0 pp-0.9 pp
EWEdwards Lifesciences CorporationLTM Jun 202624.3% -7.1 pp-12.4 pp
AORTArtivion, Inc.LTM Mar 202614.2% +5.1 pp+6.3 pp
LIVNLivaNova PLCLTM Sep 202614.0% +20.0 pp-12.4 pp
AVRAnteris Technologies Global Corp.LTM Mar 2026-5021.0% -1760.3 pp-3924.4 pp
Peer median (excluding AVR) 24.3%+2.2 pp-0.9 pp

Competitors are the stored peer set for AVR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.83M3.2M2.73M2.7M1.91M
Cost of Revenue3.93M2.9M1.86M1.44M2.23M
Gross Profit1.91M298.38K876.8K1.27M(317K)
Gross Margin32.7%9.3%32.1%46.8%-16.6%
Research & Development9.99M17.59M31.02M51.45M69.12M
Selling, General & Admin9.14M15.21M17.05M024.46M
Operating Expenses18.77M31.41M49.02M79.64M93.58M
Depreciation & Amortization640.09K774.08K1.16M1.51M1.66M
EBITDA(15.5M)(29.14M)(45.54M)(74.38M)(92.49M)
EBITDA Margin-265.8%-910.5%-1665.1%-2751.7%-4834.9%
Operating Income(16.86M)(31.11M)(48.14M)(78.37M)(93.89M)
Operating Margin-289.2%-972.1%-1760.3%-2899.4%-4908.2%
Interest Income68.55K210.38K428.06K0709K
Interest Expense1.03M648.71K67.09K82K73K
Other Income / Expenses(310.48K)550.48K1.38M2.41M(331K)
Income Before Tax(17.17M)(30.56M)(46.76M)(75.97M)(94.23M)
Pre-Tax Margin-294.5%-954.9%-1709.9%-2810.5%-4925.5%
Income Tax Expense00000
Net Income(17.17M)(30.56M)(46.02M)(76.29M)(94.14M)
Net Margin-294.5%-954.9%-1682.8%-2822.5%-4921.3%
EPS (Basic)(0.48)(0.85)(1.28)(3.77)(4.00)
EPS (Diluted)(0.48)(0.85)(1.28)(3.77)(4.00)
Weighted Avg Shares35.94M35.94M35.94M20.25M23.58M
Weighted Avg Shares (Diluted)35.94M35.94M35.94M20.25M23.58M

Anteris Technologies Global Corp.

NASDAQ:AVR

Intrinsic Alpha fair value

Locked

Current Price

$5.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.